Opinion
Video
A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.
FDA Approves Osimertinib for Unresectable EGFR-Mutated Lung Cancer